JIR
FLNA

James Investment Research’s Filana Therapeutics FLNA Stock Holding History

James Investment Research’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-23,798
Closed -$651K – 523
2014
Q3 		$651K Buy
+23,798
New +$723K 0.02% 251

Other funds holding FLNA

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

James Investment Research's FLNA Position: Q4 2014 in Review

James Investment Research sold out of Filana Therapeutics (FLNA) in Q4 2014, closing a stake of 23,798 shares — an estimated $651K sold.

James Investment Research first reported a position in FLNA in Q3 2014 and held it in 1 quarter. The position peaked at $651K in Q3 2014. 66 funds tracked by Wall St. Rank hold FLNA as of Q4 2014.

  • James Investment Research reported no remaining Filana Therapeutics position as of Q4 2014 after selling out during the quarter.
  • James Investment Research sold 23,798 Filana Therapeutics shares in Q4 2014, an estimated $651K.
  • James Investment Research first reported a position in Filana Therapeutics in Q3 2014 and held it in 1 quarter.
  • James Investment Research's Filana Therapeutics position peaked at $651K in Q3 2014.
  • 66 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2014.

Based on James Investment Research's 13F filing for Q4 2014, filed 9 Jan 2015.